1999
DOI: 10.1016/s0022-510x(99)00045-3
|View full text |Cite
|
Sign up to set email alerts
|

Bipap improves survival and rate of pulmonary function decline in patients with ALS

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

22
216
3
13

Year Published

1999
1999
2015
2015

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 352 publications
(263 citation statements)
references
References 30 publications
22
216
3
13
Order By: Relevance
“…Although FVC has been considered the most reliable tool to monitor respiratory function in patients with ALS, it is not as useful to estimate strength of respiratory muscles 20,21 . FVC is not a sufficiently sensitive test to detect early respiratory involvement in ALS, and there is only a weak correlation between FVC and parameters such as MIP and MEP 22 .…”
Section: Discussionmentioning
confidence: 99%
“…Although FVC has been considered the most reliable tool to monitor respiratory function in patients with ALS, it is not as useful to estimate strength of respiratory muscles 20,21 . FVC is not a sufficiently sensitive test to detect early respiratory involvement in ALS, and there is only a weak correlation between FVC and parameters such as MIP and MEP 22 .…”
Section: Discussionmentioning
confidence: 99%
“…Inexsufflation and use of high frequency chest wall oscillation are increasingly common and have been shown to improve ventilation [126][127][128][129]. Physical techniques such as breath stacking and assisted cough, as well as medication management (bronchodilators, anticholinergic agents), have become increasingly common in aggressive multidisciplinary treatment settings.…”
Section: Respiratory Therapiesmentioning
confidence: 99%
“…ABOUSSOUAN et al [14] also found that prognosis was improved in patients who could tolerate NIV. More recently, KLEOPA et al [15] have shown improved survival and a slower rate of decline in vital capacity (VC) in ALS/MND patients who were started on NIV once VC had fallen below 50% of the predicted value. Further research has shown an increase in energy and vitality in patients after starting NIV, despite a continuing fall in physical strength [16].…”
Section: Motor Neurone Disease/amyotrophic Lateral Sclerosismentioning
confidence: 99%